Daniel C. Martin
2018
In 2018, Daniel C. Martin earned a total compensation of $3.2M as Chief Commercial Officer at Deciphera Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $45,000 |
|---|---|
| Option Awards | $2,189,097 |
| Salary | $217,875 |
| Stock Awards | $722,000 |
| Other | $702 |
| Total | $3,174,674 |
Martin received $2.2M in option awards, accounting for 69% of the total pay in 2018.
Martin also received $45K in non-equity incentive plan, $217.9K in salary, $722K in stock awards and $702 in other compensation.
Rankings
In 2018, Daniel C. Martin's compensation ranked 3,635th out of 14,244 executives tracked by ExecPay. In other words, Martin earned more than 74.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,635 out of 14,244 | 75th |
Division Manufacturing | 1,347 out of 5,765 | 77th |
Major group Chemicals And Allied Products | 478 out of 2,128 | 78th |
Industry group Drugs | 397 out of 1,817 | 78th |
Industry Pharmaceutical Preparations | 306 out of 1,391 | 78th |
Source: SEC filing on April 22, 2019.
Martin's colleagues
We found two more compensation records of executives who worked with Daniel C. Martin at Deciphera Pharmaceuticals in 2018.